134 related articles for article (PubMed ID: 9757194)
1. [Recent controversy in treatment for advanced bladder cancer].
Ozono S; Hirao Y
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1696-700. PubMed ID: 9757194
[TBL] [Abstract][Full Text] [Related]
2. [Systemic cisplatin-based chemotherapy in the treatment of advanced bladder cancer].
Boccon-Gibod L; Guinet F; Cressey-Kanoui C; Debré B; Steg A
Ann Urol (Paris); 1985; 19(4):239-43. PubMed ID: 4040730
[TBL] [Abstract][Full Text] [Related]
3. [Intra-arterial chemotherapy for invasive bladder cancer (T2-3N0M0)].
Maruyama T; Kondoh N; Nojima M; Yamamoto S; Mori Y; Shima H; Kamikonnya N; Hirota S; Nakao N
Hinyokika Kiyo; 2006 Jun; 52(6):445-9. PubMed ID: 16848358
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
5. [Neoadjuvant chemotherapy for invasive bladder cancer].
Kageyama Y; Kihara K
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1838-44. PubMed ID: 11729476
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
Segal R; Winquist E; Lukka H; Chin JL; Brundage M; Markman BR;
Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323
[TBL] [Abstract][Full Text] [Related]
7. [Dose intensity in M-VAC chemotherapy with rG-CSF for metastatic transitional urothelial cancer].
Obata K; Kobayashi H; Takaba H; Yokoi K; Hikosaka A
Hinyokika Kiyo; 1994 Oct; 40(10):939-44. PubMed ID: 7527613
[TBL] [Abstract][Full Text] [Related]
8. Combined therapy by means of reductive surgery and polychemotherapy (M-VAC) in the treatment of advanced bladder cancer. Our experience in 10 cases.
Valente R; Marini F; Signori GB
Prog Clin Biol Res; 1988; 260():557-9. PubMed ID: 3362904
[No Abstract] [Full Text] [Related]
9. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer].
Miyanaga N; Akaza H
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1745-9. PubMed ID: 18030008
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?
Hall RR
Acta Urol Belg; 1996 May; 64(2):39-42. PubMed ID: 8701809
[No Abstract] [Full Text] [Related]
11. Overview of bladder cancer trials in the European Organization for Research and Treatment.
de Wit R;
Cancer; 2003 Apr; 97(8 Suppl):2120-6. PubMed ID: 12673705
[TBL] [Abstract][Full Text] [Related]
12. Treatment of high-stage bladder cancer: case for adjunctive chemotherapy.
Walther PJ
Semin Urol; 1993 May; 11(2):69-73. PubMed ID: 8362122
[No Abstract] [Full Text] [Related]
13. Bladder preserving combined modality therapy for invasive bladder cancer.
Held J; Volpe H
Oncol Nurs Forum; 1991; 18(1):49-57. PubMed ID: 2003116
[TBL] [Abstract][Full Text] [Related]
14. [Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
Honda M; Satoh M; Tujimoto Y; Takada T; Matsumiya K; Fujioka H
Hinyokika Kiyo; 2006 May; 52(5):331-5. PubMed ID: 16758720
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response.
Splinter TA; Denis L; Scher HI; Schröder FH; Dalesio O
Prog Clin Biol Res; 1989; 303():541-7. PubMed ID: 2675011
[No Abstract] [Full Text] [Related]
16. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
[TBL] [Abstract][Full Text] [Related]
17. [Characteristic and effective usage of adriamycin].
Horiuchi K; Akimoto M
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1916-9. PubMed ID: 8978797
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
[TBL] [Abstract][Full Text] [Related]
19. [Bladder cancer: realities and perspectives].
Chrétien Y; Oudard S; Durdux C
Bull Cancer; 2003 Jan; 90(1):61-7. PubMed ID: 12609806
[TBL] [Abstract][Full Text] [Related]
20. [Possibilities and limits of chemotherapy in multi-modality treatment of urinary bladder cancer].
Rüther U; Rassweiler J; Lüthgens M; Bub P; Jipp P; Eisenberger F
Verh Dtsch Ges Inn Med; 1989; 95():544-52. PubMed ID: 2603494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
